This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsue, P. Y. Articles by Waters, D. D. Search for Related Content PubMed PubMed Citation Articles by Hsue, P. Y. Articles by Waters, D. D. Related Collections Mechanism of atherosclerosis/growth factors Pathophysiology Risk Factors

(Circulation. 2005;112:3947-3957.)
© 2005 American Heart Association, Inc.

Contemporary Reviews in Cardiovascular Medicine

What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection

Priscilla Y. Hsue, MD; David D. Waters, MD

From the Division of Cardiology, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco.

Correspondence to David Waters, MD, Room 5G1, Division of Cardiology, San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110. E-mail dwaters{at}medsfgh.ucsf.edu

Patient case: A 48-year-old man with human immunodeficiency virus (HIV) infection developed chronic chest pain that started after a bout of pneumonia. He has hypertension and has smoked cigarettes in the past. His current medications include Kaletra and Combivir. His total cholesterol was 331 mg/L, his HDL cholesterol was 27 mg/L, his triglycerides were 935 mg/L, and his LDL cholesterol could not be calculated. How should this patient be evaluated and managed?

Key Words: AIDS • atherosclerosis • cardiovascular diseases • immune system

This article has been cited by other articles:

				M. Bukrinsky and D. Sviridov Human immunodeficiency virus infection and macrophage cholesterol metabolism. J. Leukoc. Biol., November 1, 2006; 80(5): 1044 - 1051. [Abstract] [Full Text] [PDF]